Aerobic Training and Circulating Neurotrophins in Alzheimer’s Disease Patients: A Controlled Trial
Nenhuma Miniatura disponível
Data
2022-01-01
Autores
Stein, Angelica Miki
Coelho, Flávia Gomes de Melo
Vital-Silva, Thays Martins [UNESP]
Rueda, André Veloso
Pereira, Jessica Rodrigues
Deslandes, Andréa Camaz
Camarini, Rosana
Santos Galduróz, Ruth Ferreira
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Objective: to verify the effects of aerobic exercise training in circulating BDNF, VEGF165 and IGF-1 plasma levels and cognitive function in Alzheimer’s Disease (AD) patients. Methods: 34 AD patients participated in the study, divided in two groups: Control Group (CG; n = 16) and Training Group (TG; n = 18–Moderate aerobic training on the treadmill, three times a week, for 12 weeks). BDNF, VEGF165, and IGF-1 plasma levels were considered as a primary outcome. Secondary outcomes included cognitive functions and aerobic fitness. Results: After 12 weeks, maintenance of executive functioning in the TG was found, yet no significant changes on circulating neurotrophins levels were identified. For aerobic fitness, there was an increment in TG group. Conclusion: Twelve weeks of aerobic training were neither effective in improving cognitive functioning significantly, nor influential on circulating neurotrophins levels in AD patients.
Descrição
Palavras-chave
Como citar
Experimental Aging Research.